These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 1741765)

  • 21. Studies on the metabolism of the novel antitumor agent [N-methyl-11C]N-[2-(dimethylamino)ethyl]acridine-4-carboxamide in rats and humans prior to phase I clinical trials.
    Osman S; Luthra SK; Brady F; Hume SP; Brown G; Harte RJ; Matthews JC; Denny WA; Baguley BC; Jones T; Price PM
    Cancer Res; 1997 Jun; 57(11):2172-80. PubMed ID: 9187117
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Individual variation in hepatic aldehyde oxidase activity.
    Al-Salmy HS
    IUBMB Life; 2001 Apr; 51(4):249-53. PubMed ID: 11569919
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of the principal biliary metabolite of 4'-(9-acridinylamino)methanesulfon-m-anisidide in rats.
    Shoemaker DD; Cysyk RL; Padmanabhan S; Bhat HB; Malspeis L
    Drug Metab Dispos; 1982; 10(1):35-9. PubMed ID: 6124380
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumour profile of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide after intraperitoneal administration in the mouse.
    Paxton JW; Young D; Evans SM; Robertson IG; Kestell P
    Cancer Chemother Pharmacol; 1993; 32(4):320-2. PubMed ID: 8324875
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitation of the antitumour agent N-[2-(dimethylamino)ethyl]acridine-4-carboxamide in plasma by high-performance liquid chromatography.
    Young D; Evans PC; Paxton JW
    J Chromatogr; 1990 Jun; 528(2):385-94. PubMed ID: 2384576
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Electron-deficient DNA-intercalating agents as antitumor drugs: aza analogues of the experimental clinical agent N-[2-(dimethylamino)ethyl]acridine-4-carboxamide.
    Chen Q; Deady LW; Baguley BC; Denny WA
    J Med Chem; 1994 Mar; 37(5):593-7. PubMed ID: 8126699
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Flavin monooxygenases, FMO1 and FMO3, not cytochrome P450 isoenzymes, contribute to metabolism of anti-tumour triazoloacridinone, C-1305, in liver microsomes and HepG2 cells.
    Fedejko-Kap B; Niemira M; Radominska-Pandya A; Mazerska Z
    Xenobiotica; 2011 Dec; 41(12):1044-55. PubMed ID: 21859392
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potential antitumor agents. 49. 5-substituted derivatives of N-[2-(dimethylamino)ethyl]-9-aminoacridine-4-carboxamide with in vivo solid-tumor activity.
    Denny WA; Atwell GJ; Rewcastle GW; Baguley BC
    J Med Chem; 1987 Apr; 30(4):658-63. PubMed ID: 3560160
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potential antitumor agents. 46. Structure-activity relationships for acridine monosubstituted derivatives of the antitumor agent N-[2-(dimethylamino)ethyl]-9-aminoacridine-4-carboxamide.
    Rewcastle GW; Atwell GJ; Chambers D; Baguley BC; Denny WA
    J Med Chem; 1986 Apr; 29(4):472-7. PubMed ID: 3959026
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanism of cytotoxicity of N-[2-(dimethylamino)ethyl] acridine-4-carboxamide and of its 7-chloro derivative: the roles of topoisomerases I and II.
    Bridewell DJ; Finlay GJ; Baguley BC
    Cancer Chemother Pharmacol; 1999; 43(4):302-8. PubMed ID: 10071981
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure-activity relationships for acridine-substituted analogues of the mixed topoisomerase I/II inhibitor N-[2-(dimethylamino)ethyl]acridine-4-carboxamide.
    Spicer JA; Gamage SA; Atwell GJ; Finlay GJ; Baguley BC; Denny WA
    J Med Chem; 1997 Jun; 40(12):1919-29. PubMed ID: 9191970
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Crystal structure of 9-amino-N-[2-(4-morpholinyl)ethyl]-4-acridinecarboxamide bound to d(CGTACG)2: implications for structure-activity relationships of acridinecarboxamide topoisomerase poisons.
    Adams A; Guss JM; Denny WA; Wakelin LP
    Nucleic Acids Res; 2002 Feb; 30(3):719-25. PubMed ID: 11809884
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inter-strain variability in aldehyde oxidase activity in the mouse.
    Al-Salmy HS
    Comp Biochem Physiol C Toxicol Pharmacol; 2002 Jul; 132(3):341-7. PubMed ID: 12161167
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the pharmacokinetics and protein binding of the anticancer drug, amsacrine and a new analogue, N-5-dimethyl-9-[(2-methoxy-4-methylsulfonylamino)phenyl-amino] -4-acridinecarboxamide in rabbits.
    Paxton JW; Jurlina JL
    Cancer Chemother Pharmacol; 1986; 16(3):253-6. PubMed ID: 3754493
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of acridine-4-carboxamide in the rat, with extrapolation to humans.
    Paxton JW; Young D; Robertson IG
    Cancer Chemother Pharmacol; 1993; 32(4):323-5. PubMed ID: 8324876
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolism of the lipid peroxidation product 4-hydroxynonenal by isolated hepatocytes and by liver cytosolic fractions.
    Esterbauer H; Zollner H; Lang J
    Biochem J; 1985 Jun; 228(2):363-73. PubMed ID: 3160340
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of human CYP1A2 oxidation of 5,6-dimethyl-xanthenone-4-acetic acid by acridines: a molecular modelling study.
    Paxton JW; Kestell P; Chiang D; Zhou S; Lewis DF
    Clin Exp Pharmacol Physiol; 2005 Aug; 32(8):633-9. PubMed ID: 16120190
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationships between DNA-binding kinetics and biological activity for the 9-aminoacridine-4-carboxamide class of antitumor agents.
    Wakelin LP; Atwell GJ; Rewcastle GW; Denny WA
    J Med Chem; 1987 May; 30(5):855-61. PubMed ID: 3572974
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro biotransformation and investigation of metabolic enzymes possibly responsible for the metabolism of bisdesoxyolaquindox in the liver fractions of rats, chicken, and pigs.
    Liu ZY; Chen DM; Huang LL; Tao YF; Yao M; Yuan ZH
    Toxicology; 2011 Jan; 279(1-3):155-66. PubMed ID: 20955753
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An extremely potent anilinoacridine inhibitor of aldehyde oxidase.
    Gormley PE; Rossitch E; D'Anna ME; Cysyk R
    Biochem Biophys Res Commun; 1983 Oct; 116(2):759-64. PubMed ID: 6689124
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.